Troglitazone FDA Link

A chroman and thiazolidinedione derivative that acts as a PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS (PPAR) agonist. It was formerly used in the treatment of TYPE 2 DIABETES MELLITUS, but has been withdrawn due to hepatotoxicity.

Also Known As:

Rezulin; Prelay; 5- (4- ((6- Hydroxy- 2,5,7,8- tetramethylchroman- 2- yl- methoxy)benzyl)- 2,4- thiazolidinedione) - T; CS 045; CS-045; CS045; 2,4-Thiazolidinedione, 5- ((4- ((3,4- dihydro- 6- hydroxy- 2,5,7,8- tetramethyl- 2H- 1- benzopyran- 2- yl)methoxy)phenyl)methyl)-

Organic Chemicals: 133
- Sulfur Compounds: 278
  - Thiazoles: 392
    - Thiazolidinediones: 2250
      - Troglitazone: 901
Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Azoles: 2138
    - Thiazoles: 392
      - Thiazolidinediones: 2250
        Troglitazone: 901
  - Pyrans: 130
    - Benzopyrans: 195
      - Chromans: 3
        Troglitazone: 901
- Fused-Ring Heterocyclic Compounds
  - 2-Ring Heterocyclic Compounds
    - Benzopyrans: 195
      - Chromans: 3
        Troglitazone: 901

Troglitazone Products